Your browser doesn't support javascript.
loading
Molecular subclass of uterine fibroids predicts tumor shrinkage in response to ulipristal acetate.
Kolterud, Åsa; Välimäki, Niko; Kuisma, Heli; Patomo, Joonatan; Ilves, Sini T; Mäkinen, Netta; Kaukomaa, Jaana; Palin, Kimmo; Kaasinen, Eevi; Karhu, Auli; Pasanen, Annukka; Bützow, Ralf; Heikinheimo, Oskari; Kopp Kallner, Helena; Aaltonen, Lauri A.
Affiliation
  • Kolterud Å; Department of Biosciences and Nutrition, Karolinska Institutet, 141 83 Huddinge, Sweden.
  • Välimäki N; Department of Medical and Clinical Genetics, University of Helsinki; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, 00290 Helsinki, Finland.
  • Kuisma H; Department of Medical and Clinical Genetics, University of Helsinki; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, 00290 Helsinki, Finland.
  • Patomo J; Department of Medical and Clinical Genetics, University of Helsinki; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, 00290 Helsinki, Finland.
  • Ilves ST; Department of Medical and Clinical Genetics, University of Helsinki; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, 00290 Helsinki, Finland.
  • Mäkinen N; Department of Medical and Clinical Genetics, University of Helsinki; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, 00290 Helsinki, Finland.
  • Kaukomaa J; Department of Medical and Clinical Genetics, University of Helsinki; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, 00290 Helsinki, Finland.
  • Palin K; Department of Medical and Clinical Genetics, University of Helsinki; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, 00290 Helsinki, Finland.
  • Kaasinen E; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, 00290 Helsinki, Finland.
  • Karhu A; Department of Medical and Clinical Genetics, University of Helsinki; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, 00290 Helsinki, Finland.
  • Pasanen A; Department of Medical and Clinical Genetics, University of Helsinki; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, 00290 Helsinki, Finland.
  • Bützow R; Department of Pathology, University of Helsinki and HUSLAB, Helsinki University Hospital, 00290 Helsinki, Finland.
  • Heikinheimo O; Department of Pathology, University of Helsinki and HUSLAB, Helsinki University Hospital, 00290 Helsinki, Finland.
  • Kopp Kallner H; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, 00029 HUS Helsinki, Finland.
  • Aaltonen LA; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, 00029 HUS Helsinki, Finland.
Hum Mol Genet ; 32(7): 1063-1071, 2023 03 20.
Article in En | MEDLINE | ID: mdl-36048862
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uterine Neoplasms / Leiomyoma Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Hum Mol Genet Journal subject: BIOLOGIA MOLECULAR / GENETICA MEDICA Year: 2023 Document type: Article Affiliation country: Suecia Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uterine Neoplasms / Leiomyoma Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Hum Mol Genet Journal subject: BIOLOGIA MOLECULAR / GENETICA MEDICA Year: 2023 Document type: Article Affiliation country: Suecia Country of publication: Reino Unido